TLR4 and Miyoshi myopathy: Taken together, these data demonstrate that TLR4 inhibition significantly resensitized CD138+ cells from a small group of MM patients refractory to BTZ thanks to the induction of remarkable mitochondrial depolarization associated with cell death.